SHANGHAI, Aug. 4, 2025 /PRNewswire/ — Aphranel, China’s leading innovator of regenerative aesthetics medicine, recently made waves at IMCAS China 2025 with its 36㎡ platinum sponsorship booth, hosted a 60-minute scientific symposium and 30-minute live-case with its breakthrough product Aphranel® MagiCCrystal CaHA Filler.
IMCAS leadership including Congress Chair Prof. Cui Haiyan, IMCAS Paris Chairmen Dr. Cartier and Dr. Garson visited Aphranel, recognizing its significant contributions to global industry of regenerative aesthetics medicine. This high-profile exhibiting in IMCAS China, demonstrated the Aphranel’s growing influence on the advanced anti-aging solutions in the global market.
About Aphranel
Aphranel® is a high-profile medical aesthetics brand under Shanghai MOYOM Biotechnology, dedicated to advancing global aesthetics technology through cutting-edge biomaterial innovation.
ข่าวที่เกี่ยวข้อง
- HONGQI EHS4 Set for Global Debut in Venice: Eastern Elegance Arrives in Europe
- EFICYENT เตรียมร่วมงาน Singapore FinTech Festival 2026 พร้อมธนาคารและบริษัทฟินเทคชั้นนำ
- EFICYENT to Join Banks and Fintech Companies at Singapore FinTech Festival 2026
- SmallRig Joins Art World Figures to Discuss Creativity and Authenticity in the AI Era–and How Art and Technology Can Drive Innovation
